Home »
Rulemaking » Comment submitted by Michael Garvin, Pharm.D., Assistant Vice President, Scientifice and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
Comment submitted by Michael Garvin, Pharm.D., Assistant Vice President, Scientifice and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
Document ID: EPA-HQ-OAR-2008-0008-0078
Document Type: Public Submission
Agency: Environmental Protection Agency
Received Date: November 24 2008, at 11:25 AM Eastern Standard Time
Date Posted: November 25 2008, at 12:00 AM Eastern Standard Time
Comment Start Date: October 10 2008, at 12:00 AM Eastern Standard Time
Comment Due Date: November 24 2008, at 11:59 PM Eastern Standard Time
Comment submitted by Michael Garvin, Pharm.D., Assistant Vice President, Scientifice and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
Title: Comment submitted by Michael Garvin, Pharm.D., Assistant Vice President, Scientifice and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
View Attachment:
Comment submitted by Michael Garvin, Pharm.D., Assistant Vice President, Scientifice and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA) (2)
Title: Comment submitted by Michael Garvin, Pharm.D., Assistant Vice President, Scientifice and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA) (2)
Comment submitted by Michael Garvin, Pharm.D., Assistant Vice President, Scientifice and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
This is comment on Proposed Rule
National Emission Standards for Hazardous Air Pollutant Emissions: Group I Polymers and Resins (Epichlorohydrin Elastomers Production, Hypalon\TM\ Production, Nitrile Butadiene Rubber Production, Polybutadiene Rubber Production, and Styrene Butadiene Rubber and Latex Production); Marine Vessel Loading Operations; Mineral Wool Production; Pharmaceuticals Production; and Printing and Publishing Indu
Attachments:
Comment submitted by Michael Garvin, Pharm.D., Assistant Vice President, Scientifice and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
Title:
Comment submitted by Michael Garvin, Pharm.D., Assistant Vice President, Scientifice and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)
Comment submitted by Michael Garvin, Pharm.D., Assistant Vice President, Scientifice and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA) (2)
Title:
Comment submitted by Michael Garvin, Pharm.D., Assistant Vice President, Scientifice and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA) (2)
Related Comments
View AllPublic Submission Posted: 11/07/2008 ID: EPA-HQ-OAR-2008-0008-0069
Nov 24,2008 11:59 PM ET
Public Submission Posted: 11/21/2008 ID: EPA-HQ-OAR-2008-0008-0070
Nov 24,2008 11:59 PM ET
Public Submission Posted: 11/24/2008 ID: EPA-HQ-OAR-2008-0008-0071
Nov 24,2008 11:59 PM ET
Public Submission Posted: 11/25/2008 ID: EPA-HQ-OAR-2008-0008-0072
Nov 24,2008 11:59 PM ET
Public Submission Posted: 11/25/2008 ID: EPA-HQ-OAR-2008-0008-0075
Nov 24,2008 11:59 PM ET